Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry.

Neurology. Clinical practice·2026
Same author

Factors Associated With the Rising Trend in Self-Reported Cognitive Disability Among U.S. Adults Aged 18-39 From 2013-2024.

Annals of clinical and translational neurology·2026
Same author

Endovascular Thrombectomy in Medium and Distal Vessel Occlusions: A Focused Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.

Stroke (Hoboken, N.J.)·2026
Same author

Final Infarct Volume as a Surrogate End Point in Anterior Circulation ICAS-LVO Stroke: Post Hoc Secondary Analysis of RESCUE-ICAS.

Stroke (Hoboken, N.J.)·2026
Same author

The Financial Value of an Academic Neurologist.

Annals of neurology·2026
Same author

Development and External Validation of an Electronic Health Record-Derived Model for 30-Day Periprocedural Ischemic Stroke.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jul 8, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.3K

Disability and Recurrent Stroke Among Participants in Stroke Prevention Trials.

Adam de Havenon1, Catherine Viscoli2, Dawn Kleindorfer3

  • 1Department of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, Connecticut.

JAMA Network Open
|July 19, 2024
PubMed
Summary

Higher poststroke disability increases the risk of recurrent stroke and major cardiovascular events (MACE). Including more disabled patients in stroke prevention trials could enhance study power and generalizability.

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

2.9K
Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

862

Related Experiment Videos

Last Updated: Jul 8, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.3K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

2.9K
Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

862

Area of Science:

  • Neurology
  • Cardiology
  • Clinical Trials

Background:

  • Stroke secondary prevention trials often exclude individuals with significant poststroke disability.
  • The impact of this enrollment bias on trial outcomes and generalizability is not well understood.

Purpose of the Study:

  • To examine the association between the level of functional disability after a stroke and the long-term risk of experiencing a recurrent stroke.
  • To investigate the relationship between poststroke disability and the occurrence of major adverse cardiovascular events (MACE).

Main Methods:

  • A post hoc analysis was conducted using data from two large clinical trials: the Prevention Regimen For Effectively Avoiding Second Strokes (PRoFESS) and the Insulin Resistance Intervention After Stroke (IRIS).
  • Participants were categorized based on their modified Rankin Scale (mRS) score at baseline, indicating their level of disability (0, 1-2, or 3+).
  • Recurrent stroke and MACE rates were compared across disability groups using statistical analysis, including hazard ratios.

Main Results:

  • Higher baseline disability (mRS 3+) was significantly associated with increased rates of recurrent stroke in both PRoFESS and IRIS trials.
  • Patients with greater disability also showed a higher incidence of MACE compared to those with no or mild disability.
  • Hazard ratios indicated a significantly increased risk for recurrent stroke and MACE in individuals with higher mRS scores.

Conclusions:

  • Baseline poststroke functional status is a critical factor influencing the risk of recurrent stroke and MACE.
  • Clinical trials for stroke secondary prevention should aim to include a broader spectrum of patients, including those with moderate to severe disability.
  • Increased inclusion of disabled participants can improve the statistical power and real-world applicability of stroke prevention research.